Mitchell Chan - 01 Dec 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
Christopher R. Sullivan, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
01 Dec 2021
Net transactions value
$0
Form type
4
Filing time
03 Dec 2021, 19:44:41 UTC
Next filing
15 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +80,000 $0.000000 80,000 01 Dec 2021 Common Stock 80,000 $1.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest in three substantially equal installments on December 1, 2022, December 1, 2023 and December 1, 2024, subject to the Reporting Person's continued service on each such vesting date.